The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study

ObjectivesGiven the high occurrence of asymptomatic subsets, the true prevalence of SARS-CoV-2 infection in rheumatic patients is still underestimated. This study aims to evaluate the seroprevalence of SARS-CoV-2 antibodies in rheumatic musculoskeletal diseases (RMD) patients receiving immunomodulat...

Descripción completa

Detalles Bibliográficos

Autores principales:	Ennio Giulio Favalli, Andrea Gobbini, Mauro Bombaci, Gabriella Maioli, Martina Biggioggero, Elisa Pesce, Andrea Favalli, Martina Martinovic, Tanya Fabbris, Edoardo Marchisio, Alessandra Bandera, Andrea Gori, Sergio Abrignani, Renata Grifantini, Roberto Caporali
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2022-03-01
Colección:	Frontiers in Medicine
Materias:	seroprevalence SARS-CoV-2 humoral response rheumatic musculoskeletal diseases disease-modifying anti-rheumatic drugs risk of infection
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fmed.2022.850858/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!